Norges Bank Portfolio holdings
Norges Bank, established in 1816 and headquartered in Oslo, Norway, serves as the central bank of Norway, responsible for monetary policy, issuing the Norwegian krone, and maintaining financial stability. Beyond its traditional central banking role, it oversees the management of the Government Pension Fund Global (often called the Norwegian Oil Fund), one of the world’s largest sovereign wealth funds, valued at over $1 trillion, which invests Norway’s oil and gas revenues in global equities, bonds, and real estate. The fund’s investment arm, Norges Bank Investment Management (NBIM), operates independently to ensure long-term wealth preservation for future generations, emphasizing sustainable and ethical investing practices. With its dual role, Norges Bank uniquely blends central banking duties with stewardship of a massive global investment portfolio.
Top Buys
| 1 |
Microsoft
MSFT
|
+$1.45B |
| 2 |
Broadcom
AVGO
|
+$1.33B |
| 3 |
Bank of America
BAC
|
+$1.02B |
| 4 |
Amazon
AMZN
|
+$818M |
| 5 |
Simon Property Group
SPG
|
+$802M |
Top Sells
| 1 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$1.2B |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$822M |
| 3 |
Kenvue
KVUE
|
+$552M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$542M |
| 5 |
RTX Corp
RTX
|
+$533M |
Sector Composition
| 1 | Technology | 28.38% |
| 2 | Financials | 13.95% |
| 3 | Healthcare | 11.94% |
| 4 | Consumer Discretionary | 11.37% |
| 5 | Communication Services | 8.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Unitil
UTL
$805M
| $1.45M | ﹤0.01% |
27,500
+10,100
| +58% | +$531K |
|
1827
Keros Therapeutics
KROS
$638M
| $1.42M | ﹤0.01% |
35,700
-61,700
| -63% | -$2.45M |
|
|
RVNC
1828
DELISTED
Revance Therapeutics, Inc.
RVNC
| $1.42M | ﹤0.01% |
161,000
| – | – |
|
1829
Krystal Biotech
KRYS
$4.09B
| $1.41M | ﹤0.01% |
11,340
-6,796
| -37% | -$843K |
|
1830
uniQure
QURE
$960M
| $1.4M | ﹤0.01% |
207,100
| – | – |
|
1831
Intapp
INTA
$3.71B
| $1.4M | ﹤0.01% |
36,800
-41,400
| -53% | -$1.57M |
|
1832
MaxLinear
MXL
$1.4B
| $1.37M | ﹤0.01% |
57,819
-291,605
| -83% | -$6.93M |
|
1833
Biohaven
BHVN
$1.53B
| $1.36M | ﹤0.01% |
+31,888
| New | +$1.36M |
|
1834
ProPetro Holding
PUMP
$470M
| $1.35M | ﹤0.01% |
+161,400
| New | +$1.35M |
|
1835
Heidrick & Struggles
HSII
$1.04B
| $1.35M | ﹤0.01% |
+45,800
| New | +$1.35M |
|
1836
The Beauty Health Co
SKIN
$309M
| $1.31M | ﹤0.01% |
421,791
-134,409
| -24% | -$418K |
|
1837
CureVac
CVAC
$1.21B
| $1.3M | ﹤0.01% |
308,675
-73,171
| -19% | -$308K |
|
1838
Ingles Markets
IMKTA
$1.31B
| $1.26M | ﹤0.01% |
+14,600
| New | +$1.26M |
|
1839
Ambac
AMBC
$424M
| $1.24M | ﹤0.01% |
75,000
| – | – |
|
1840
Camtek
CAMT
$3.78B
| $1.23M | ﹤0.01% |
17,363
-18,409
| -51% | -$1.3M |
|
1841
Limbach Holdings
LMB
$1.2B
| $1.21M | ﹤0.01% |
+26,511
| New | +$1.21M |
|
1842
Bankunited
BKU
$2.89B
| $1.2M | ﹤0.01% |
37,118
-319,777
| -90% | -$10.4M |
|
1843
BioAtla
BCAB
$41.9M
| $1.2M | ﹤0.01% |
488,191
| – | – |
|
|
GMS
1844
DELISTED
GMS Inc
GMS
| $1.18M | ﹤0.01% |
14,324
| – | – |
|
|
CDMO
1845
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $1.17M | ﹤0.01% |
180,700
+19,700
| +12% | +$128K |
|
|
LICY
1846
DELISTED
Li-Cycle Holdings Corp.
LICY
| $1.17M | ﹤0.01% |
250,000
| – | – |
|
1847
Surmodics
SRDX
$470M
| $1.15M | ﹤0.01% |
+31,600
| New | +$1.15M |
|
1848
Kenon Holdings
KEN
$2.4B
| $1.14M | ﹤0.01% |
46,803
+23,745
| +103% | +$577K |
|
|
CRGX
1849
DELISTED
CARGO Therapeutics
CRGX
| $1.13M | ﹤0.01% |
+48,797
| New | +$1.13M |
|
|
INN
1850
Summit Hotel Properties
INN
$608M
| $1.12M | ﹤0.01% |
166,600
-50,300
| -23% | -$338K |
|